172 related articles for article (PubMed ID: 25760146)
1. 3'-functionalized adamantyl cannabinoid receptor probes.
Ogawa G; Tius MA; Zhou H; Nikas SP; Halikhedkar A; Mallipeddi S; Makriyannis A
J Med Chem; 2015 Apr; 58(7):3104-16. PubMed ID: 25760146
[TBL] [Abstract][Full Text] [Related]
2. Adamantyl cannabinoids: a novel class of cannabinergic ligands.
Lu D; Meng Z; Thakur GA; Fan P; Steed J; Tartal CL; Hurst DP; Reggio PH; Deschamps JR; Parrish DA; George C; Järbe TU; Lamb RJ; Makriyannis A
J Med Chem; 2005 Jul; 48(14):4576-85. PubMed ID: 15999995
[TBL] [Abstract][Full Text] [Related]
3. Heteroadamantyl cannabinoids.
Dixon DD; Sethumadhavan D; Benneche T; Banaag AR; Tius MA; Thakur GA; Bowman A; Wood JT; Makriyannis A
J Med Chem; 2010 Aug; 53(15):5656-66. PubMed ID: 20593789
[TBL] [Abstract][Full Text] [Related]
4. Oxaza adamantyl cannabinoids. A new class of cannabinoid receptor probes.
Le Goanvic D; Tius MA
J Org Chem; 2006 Sep; 71(20):7800-4. PubMed ID: 16995689
[TBL] [Abstract][Full Text] [Related]
5. Oxa-adamantyl cannabinoids.
Ho TC; Tius MA; Nikas SP; Tran NK; Tong F; Zhou H; Zvonok N; Makriyannis A
Bioorg Med Chem Lett; 2021 Apr; 38():127882. PubMed ID: 33636308
[TBL] [Abstract][Full Text] [Related]
6. Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.
Lu D; Guo J; Duclos RI; Bowman AL; Makriyannis A
J Med Chem; 2008 Oct; 51(20):6393-9. PubMed ID: 18826296
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and testing of novel classical cannabinoids: exploring the side chain ligand binding pocket of the CB1 and CB2 receptors.
Nadipuram AK; Krishnamurthy M; Ferreira AM; Li W; Moore BM
Bioorg Med Chem; 2003 Jul; 11(14):3121-32. PubMed ID: 12818675
[TBL] [Abstract][Full Text] [Related]
8. C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
Dixon DD; Tius MA; Thakur GA; Zhou H; Bowman AL; Shukla VG; Peng Y; Makriyannis A
Bioorg Med Chem Lett; 2012 Aug; 22(16):5322-5. PubMed ID: 22796181
[TBL] [Abstract][Full Text] [Related]
9. Novel adamantyl cannabinoids as CB1 receptor probes.
Thakur GA; Bajaj S; Paronis C; Peng Y; Bowman AL; Barak LS; Caron MG; Parrish D; Deschamps JR; Makriyannis A
J Med Chem; 2013 May; 56(10):3904-21. PubMed ID: 23621789
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.
Papahatjis DP; Kourouli T; Abadji V; Goutopoulos A; Makriyannis A
J Med Chem; 1998 Mar; 41(7):1195-200. PubMed ID: 9544219
[TBL] [Abstract][Full Text] [Related]
11. Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists.
Jiang S; Iliopoulos-Tsoutsouvas C; Tong F; Brust CA; Keenan CM; Raghav JG; Hua T; Wu S; Ho JH; Wu Y; Grim TW; Zvonok N; Thakur GA; Liu ZJ; Sharkey KA; Bohn LM; Nikas SP; Makriyannis A
J Med Chem; 2021 Apr; 64(7):3870-3884. PubMed ID: 33761251
[TBL] [Abstract][Full Text] [Related]
12. Controlled-deactivation cannabinergic ligands.
Sharma R; Nikas SP; Paronis CA; Wood JT; Halikhedkar A; Guo JJ; Thakur GA; Kulkarni S; Benchama O; Raghav JG; Gifford RS; Järbe TU; Bergman J; Makriyannis A
J Med Chem; 2013 Dec; 56(24):10142-57. PubMed ID: 24286207
[TBL] [Abstract][Full Text] [Related]
13. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
14. High affinity electrophilic and photoactivatable covalent endocannabinoid probes for the CB1 receptor.
Li C; Xu W; Vadivel SK; Fan P; Makriyannis A
J Med Chem; 2005 Oct; 48(20):6423-9. PubMed ID: 16190768
[TBL] [Abstract][Full Text] [Related]
15. Methods for the synthesis of cannabinergic ligands.
Thakur GA; Nikas SP; Duclos RI; Makriyannis A
Methods Mol Med; 2006; 123():113-48. PubMed ID: 16506405
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.
Papahatjis DP; Nikas SP; Kourouli T; Chari R; Xu W; Pertwee RG; Makriyannis A
J Med Chem; 2003 Jul; 46(15):3221-9. PubMed ID: 12852753
[TBL] [Abstract][Full Text] [Related]
17. C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.
Papahatjis DP; Nahmias VR; Nikas SP; Andreou T; Alapafuja SO; Tsotinis A; Guo J; Fan P; Makriyannis A
J Med Chem; 2007 Aug; 50(17):4048-60. PubMed ID: 17672444
[TBL] [Abstract][Full Text] [Related]
18. Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.
Papahatjis DP; Nahmias VR; Andreou T; Fan P; Makriyannis A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1616-20. PubMed ID: 16387492
[TBL] [Abstract][Full Text] [Related]
19. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
[TBL] [Abstract][Full Text] [Related]
20. Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.
Alapafuja SO; Nikas SP; Ho TC; Tong F; Benchama O; Makriyannis A
Molecules; 2019 Oct; 24(19):. PubMed ID: 31581433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
